Helius Medical Tech jumps on FDA's breakthrough designation for balance device

Solana Co

17/08/2021 12:47

** Shares of the neurological wellness company  HSDT.O  rise
12.5% premarket to $16.16; set for best session in nearly five
months
    ** Helius Medical Tech says it received breakthrough
designation from FDA for its PoNS device as a temporary
treatment for dynamic gait and balance deficits due to stroke
 urn:newsml:reuters.com:*:nFWN2PO0EQ
    ** Breakthrough designation allows to expedite development
and review of drugs that may demonstrate substantial improvement
over available therapy
    ** Portable Neuromodulation Stimulator (PoNS) is a
non-surgical device that delivers electrical stimulation to the
tongue to help with balance 
    ** HSDT up ~9% YTD, as of last close 

 (Reporting by Susan Mathew)
 ((susan.mathew@thomsonreuters.com))